Health Condition 1: O- Medical and Surgical
Conditions
Interventions
Intervention1: Group A: After fetal delivery, all patients will receive 1 gram of calcium chloride in 100 mL of sterile saline over the course of 15 minutes. Patients will continue to receive all stan
Sponsors
All India Institute of Medical Sciences Patna
Eligibility
Inclusion criteria
Inclusion criteria: Pregnant patients undergoing caesarean section in spinal anaesthesia will be included in the study. - Patients in labor. - Patients receiving an oxytocin infusion for labor augmentation prior to caesarean. - Uncomplicated, singleton pregnancy - ASA class 1 & 2.
Exclusion criteria
Exclusion criteria: - Patients with multiple pregnancies - Complicated pregnancies - Underlying cardiac condition or history of arrhythmia. - Contraindication to spinal anaesthesia.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To measure the total estimated blood loss (EBL) in intraoperative period after the intravenous calcium chloride and 7.5U/h oxytocin infusion and 7.5 U/h of oxytocin alone during caesarean section under spinal anaesthesia.Timepoint: Intraoperative period | — |
Secondary
| Measure | Time frame |
|---|---|
| - Adequacy of uterine tone. - Need for additional uterotonics. - Incidence of postpartum haemorrhage (PPH). - Any calcium chloride-related side effects for example: arrhythmia, bradycardia, hypotension, nausea, vomiting, chest pain. Timepoint: Intraaoperative period | — |
Countries
India
Contacts
Public ContactKunal Singh
All India Institute of Medical Sciences Patna
Outcome results
None listed